Metraipolis › archive › dc_fd21bcbaf424
Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant… — Europe PMC PMID:41870042
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41870042
- DOI
- 10.1128/aac.01860-25
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T02:11:28.966Z
- SHA-256 of the archived text
a88dff1fe0661fff6ca01898c82b38230f5905f57d37eb89e8006414f957cdd6- Stable URL of this page
https://metraipolis.com/documento/dc_fd21bcbaf424
How to cite
Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant… — Europe PMC PMID:41870042 — Europe PMC (en), https://europepmc.org/article/MED/41870042 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd21bcbaf424 (Metraipolis archive dc_fd21bcbaf424, sha256 a88dff1fe0661fff6ca01898c82b38230f5905f57d37eb89e8006414f957cdd6)
BibTeX
@misc{dcfd21bcbaf424,
title = {Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant… — Europe PMC PMID:41870042},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41870042},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd21bcbaf424; sha256 a88dff1fe0661fff6ca01898c82b38230f5905f57d37eb89e8006414f957cdd6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41870042. Agents can read the archived copy with the MCP tool read_document.